The Growing Problem of Illicit Substance Abuse in the Elderly: A Review

Autor Taylor, Matthew H., Grossberg, George T.
Vydáno 2012

TRPM1 Autoantibodies in Melanoma Patients Without Self-Reported Visual Symptoms

Autor Duvoisin, Robert M., Ren, Gaoying, Haley, Tammie L., Taylor, Matthew H., Morgans, Catherine W.
Vydáno v Invest Ophthalmol Vis Sci (2019)

Treatment patterns, health state, and health care resource utilization of patients with radioactive iodine refractory differentiated thyroid cancer

Autor Gianoukakis, Andrew G, Flores, Natalia M, Pelletier, Corey L, Forsythe, Anna, Wolfe, Gregory R, Taylor, Matthew H
Vydáno v Cancer Manag Res (2016)

The Acetyltransferase Activity of CBP Is Required for wingless Activation and H4 Acetylation in Drosophila melanogaster

Autor Ludlam, William H., Taylor, Matthew H., Tanner, Kirk G., Denu, John M., Goodman, Richard H., Smolik, Sarah M.
Vydáno 2002

A mutation-specific, single-arm, phase 2 study of dovitinib in patients with advanced malignancies

Autor Taylor, Matthew H., Alva, Ajjai S., Larson, Timothy, Szpakowski, Sebastian, Purkaystha, Das, Amin, Alpesh, Karpiak, Linda, Piha-Paul, Sarina A.
Vydáno v Oncotarget (2020)

Prediction of Thorough QT study results using action potential simulations based on ion channel screens

Autor Mirams, Gary R., Davies, Mark R., Brough, Stephen J., Bridgland-Taylor, Matthew H., Cui, Yi, Gavaghan, David J., Abi-Gerges, Najah
Vydáno v J Pharmacol Toxicol Methods (2014)

The ploidy-conveyor of mature hepatocytes as a source of genetic variation

Autor Duncan, Andrew W., Taylor, Matthew H., Hickey, Raymond D., Hanlon Newell, Amy E., Lenzi, Michelle L., Olson, Susan B., Finegold, Milton J., Grompe, Markus
Vydáno 2010

Phase IB/II Trial of Lenvatinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma, Endometrial Cancer, and Other Selected Advanced Solid Tumors

Autor Taylor, Matthew H., Lee, Chung-Han, Makker, Vicky, Rasco, Drew, Dutcus, Corina E., Wu, Jane, Stepan, Daniel E., Shumaker, Robert C., Motzer, Robert J.
Vydáno v J Clin Oncol (2020)

Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial

Autor Kiyota, Naomi, Robinson, Bruce, Shah, Manisha, Hoff, Ana O., Taylor, Matthew H., Li, Di, Dutcus, Corina E., Lee, Eun Kyung, Kim, Sung-Bae, Tahara, Makoto
Vydáno v Thyroid (2017)

Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies

Autor Ansell, Stephen M., Flinn, Ian, Taylor, Matthew H., Sikic, Branimir I., Brody, Joshua, Nemunaitis, John, Feldman, Andrew, Hawthorne, Thomas R., Rawls, Tracey, Keler, Tibor, Yellin, Michael J.
Vydáno v Blood Adv (2020)

Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer

Autor Robinson, Bruce, Schlumberger, Martin, Wirth, Lori J., Dutcus, Corina E., Song, James, Taylor, Matthew H., Kim, Sung-Bae, Krzyzanowska, Monika K., Capdevila, Jaume, Sherman, Steven I., Tahara, Makoto
Vydáno v J Clin Endocrinol Metab (2016)

Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: a phase 2, open-label, single-arm study

Autor Piha-Paul, Sarina A., Taylor, Matthew H., Spitz, Daniel, Schwartzberg, Lee, Beck, J. Thaddeus, Bauer, Todd M., Meric-Bernstam, Funda, Purkayastha, Das, Karpiak, Linda, Szpakowski, Sebastian, Braiteh, Fadi
Vydáno v Oncotarget (2019)

Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials

Autor Kelly, Karen, Infante, Jeffrey R., Taylor, Matthew H., Patel, Manish R., Wong, Deborah J., Iannotti, Nicholas, Mehnert, Janice M., Loos, Anja H., Koch, Helga, Speit, Isabell, Gulley, James L.
Vydáno v Cancer (2018)

Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial

Autor Keilholz, Ulrich, Mehnert, Janice M., Bauer, Sebastian, Bourgeois, Hugues, Patel, Manish R., Gravenor, Donald, Nemunaitis, John J., Taylor, Matthew H., Wyrwicz, Lucjan, Lee, Keun-Wook, Kasturi, Vijay, Chin, Kevin, von Heydebreck, Anja, Gulley, James L.
Vydáno v J Immunother Cancer (2019)

Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis

Autor Apolo, Andrea B, Ellerton, John A, Infante, Jeffrey R, Agrawal, Manish, Gordon, Michael S, Aljumaily, Raid, Gourdin, Theodore, Dirix, Luc, Lee, Keun-Wook, Taylor, Matthew H, Schöffski, Patrick, Wang, Ding, Ravaud, Alain, Manitz, Juliane, Pennock, Gregory, Ruisi, Mary, Gulley, James L, Patel, Manish R
Vydáno v J Immunother Cancer (2020)

Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial

Autor Disis, Mary L., Taylor, Matthew H., Kelly, Karen, Beck, J. Thaddeus, Gordon, Michael, Moore, Kathleen M., Patel, Manish R., Chaves, Jorge, Park, Haeseong, Mita, Alain C., Hamilton, Erika P., Annunziata, Christina M., Grote, Hans Juergen, von Heydebreck, Anja, Grewal, Jaspreet, Chand, Vikram, Gulley, James L.
Vydáno v JAMA Oncol (2019)

Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma: Phase 1b Results From the JAVELIN Solid Tumor Trial

Autor Hassan, Raffit, Thomas, Anish, Nemunaitis, John J., Patel, Manish R., Bennouna, Jaafar, Chen, Franklin L., Delord, Jean-Pierre, Dowlati, Afshin, Kochuparambil, Samith T., Taylor, Matthew H., Powderly, John D., Vaishampayan, Ulka N., Verschraegen, Claire, Grote, Hans Juergen, von Heydebreck, Anja, Chin, Kevin, Gulley, James L.
Vydáno v JAMA Oncol (2019)

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

Autor Makker, Vicky, Taylor, Matthew H., Aghajanian, Carol, Oaknin, Ana, Mier, James, Cohn, Allen L., Romeo, Margarita, Bratos, Raquel, Brose, Marcia S., DiSimone, Christopher, Messing, Mark, Stepan, Daniel E., Dutcus, Corina E., Wu, Jane, Schmidt, Emmett V., Orlowski, Robert, Sachdev, Pallavi, Shumaker, Robert, Casado Herraez, Antonio
Vydáno v J Clin Oncol (2020)

Academic Cancer Center Phase I Program Development

Autor Frankel, Arthur E., Flaherty, Keith T., Weiner, George J., Chen, Robert, Azad, Nilofer S., Pishvaian, Michael J., Thompson, John A., Taylor, Matthew H., Mahadevan, Daruka, Lockhart, A. Craig, Vaishampayan, Ulka N., Berlin, Jordan D., Smith, David C., Sarantopoulos, John, Riese, Matthew, Saleh, Mansoor N., Ahn, Chul, Frenkel, Eugene P.
Vydáno v Oncologist (2017)

SUN-LB75 The Anti-Tumor Activity of the Selective Ret Inhibitor Selpercatinib (LOXO-292) in Medullary Thyroid Cancer Is Independent of the Specific RET Mutation

Autor Cabanillas, Maria E, Wirth, Lori J, Sherman, Eric J, Drilon, Alexander, Solomon, Benjamin, Robinson, Bruce G, Lorch, Jochen H, McCoach, Caroline, Patel, Jyoti, Leboulleux, Sophie, Worden, Francis, Owonikoko, Taofeek K, Brose, Marcia S, Taylor, Matthew H, Subbiah, Vivek, Rothenberg, S Michael, Huang, Xin, Zhu, Edward, French, Pearl P, Shah, Manisha H
Vydáno v J Endocr Soc (2020)